The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem.

PloS one

Volumn 8, Issue 9, 2013, Pages

  Secher, Thomas ^a   Fas, Stefanie ^b   Fauconnier, Louis ^b   Mathieu, Marieke ^b   Rutschi, Oliver ^b   Ryffel, Bernhard ^b   Rudolf, Michael ^b  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; MEROPENEM; MONOCLONAL ANTIBODY; THIENAMYCIN DERIVATIVE;

ACUTE DISEASE; ANIMAL; ANTIBIOTIC RESISTANCE; C57BL MOUSE; COMPLICATION; DRUG EFFECTS; DRUG POTENTIATION; FEMALE; IMMUNOLOGY; LUNG; MICROBIOLOGY; MOUSE; NEUTROPENIA; PHYSIOLOGY; PNEUMONIA; PSEUDOMONAS AERUGINOSA;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; FEMALE; LUNG; MICE; MICE, INBRED C57BL; NEUTROPENIA; PNEUMONIA; PSEUDOMONAS AERUGINOSA; THIENAMYCINS;

EID: 84896473918     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073396     Document Type: Article

References (0)